SGLT2 Inhibitors and Perioperative Period
NCT06326528 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-03-22
Summary
The expanded use of SGLT2 inhibitors motivates us to assess the role of SGLT2 inhibitors in perioperative period on patients who will undergo cardiac surgery in Assiut University.
Conditions
- Perioperative Complication
Interventions
- DRUG
-
SGLT2 inhibitor
Dapagliflozin 10 mg or Empagliflozin 25mg
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Salma M Taha, MD · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-01
- Primary Completion
- 2025-04-01
- Completion
- 2025-10-01
More Related Trials
-
Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?
NCT00468494 ·Status: COMPLETED
-
Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?
NCT00899483 ·Status: UNKNOWN ·Phase: NA
-
Incidence, Characterisation and Outcome-relevance of Perioperative SGLT2 Inhibitor Associated Ketoacidosis
NCT06838507 ·Status: NOT_YET_RECRUITING
-
SHOrt-term Glycemic Control for Reducing Post-SURGical Complications
NCT06334068 ·Status: COMPLETED ·Phase: NA
-
Perioperative Versus Postoperative Glycemia Control in Cardiac Surgery Patients
NCT01548963 ·Status: COMPLETED ·Phase: NA
-
Impact of Blood Glucose Levels on in ICU Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
NCT06453967 ·Status: NOT_YET_RECRUITING
-
Carbohydrate Loading on Insulin Resistance in Open Heart Surgery
NCT06901947 ·Status: COMPLETED ·Phase: NA
-
Does Insulin Requirement Post Cardiac Surgery Predicts The Risk Of Developing Diabetes
NCT04765982 ·Status: UNKNOWN ·Phase: NA
-
Glucose Control in Open Heart Surgery
NCT00370643 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Tight Glycemic Control on Surgical Site Infection Rates in Patients Undergoing Open Heart Surgery
NCT01831154 ·Status: COMPLETED ·Phase: NA
-
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
NCT00836329 ·Status: COMPLETED ·Phase: PHASE3
-
Basal Insulin Strategies Before Surgery
NCT03104738 ·Status: COMPLETED ·Phase: NA
-
Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery
NCT04284722 ·Status: UNKNOWN ·Phase: PHASE4
-
Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control
NCT00460499 ·Status: COMPLETED ·Phase: PHASE1
-
Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery
NCT01361594 ·Status: COMPLETED ·Phase: PHASE3
-
Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients
NCT04824586 ·Status: COMPLETED ·Phase: PHASE4
-
Developing and Testing an Implementation Strategy to Improve Perioperative Diabetes Care
NCT01610674 ·Status: COMPLETED ·Phase: NA
-
Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes
NCT00826007 ·Status: COMPLETED
-
Intravenous Bolus-infusion Versus Sliding Scale of Insulin for Intra-operative Glycemic Control
NCT05136157 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality
NCT00487162 ·Status: TERMINATED ·Phase: NA
-
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
NCT01033916 ·Status: COMPLETED ·Phase: NA
-
Tight Glycaemic Control During Cardiac Surgery
NCT01225159 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery
NCT01971047 ·Status: WITHDRAWN ·Phase: PHASE4
-
Perioperative Insulin Glargine Dosing Study
NCT00309465 ·Status: COMPLETED ·Phase: PHASE4
-
Perioperative Glucose and Insulin Changes in Major Urologic Surgeries
NCT05222659 ·Status: COMPLETED